| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.04 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.32 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |